132 results
8-K
ARCT
Arcturus Therapeutics Holdings Inc
8 May 24
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
4:05pm
Litigation Reform Act of 1995. Any statements, other than statements of historical fact included in this press release, are forward-looking statements
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
8 May 24
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
4:05pm
substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements
8-K
ARCT
Arcturus Therapeutics Holdings Inc
19 Mar 24
Regulation FD Disclosure
6:00am
for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical
8-K/A
athde27p3
14 Mar 24
Results of Operations and Financial Condition
9:05am
8-K
qs7vspli12pnnhqgb
7 Mar 24
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
4:05pm
8-K
EX-99.1
yeaogqrxb0 99t7mue
7 Mar 24
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
4:05pm
8-K
0jzbvs vycio8
14 Nov 23
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update
4:10pm
8-K
EX-99.1
2eqevcpgifexz ai5
14 Nov 23
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update
4:10pm
8-K
EX-99.1
xdjp4kutp ng7l548
26 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.1
wnzgd4qlxxuofppyul
14 Aug 23
Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government
12:00am
8-K
s447 5j6drh3g
7 Aug 23
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
4:23pm
8-K
EX-99.1
1a6 j9xexegc
7 Aug 23
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
4:23pm
8-K
ui49tq5
14 Jul 23
Regulation FD Disclosure
7:53am